Biomedical Consideration in the Manufacture, Clinical Trial and Bioequivalence Studies of Pharmaceuticals

ABM Faroque
2012 Bangladesh Journal of Bioethics  
Bangladesh pharmaceutical sector has been growing at a remarkable speed since 1982. From the meager 30% national market share, now it is supplying 97% of our annual demand. Around 1,100 generics are now available in a total of around 12,000 trade name products. The national market size has crossed 6,000 crore taka per annum, where the local multinational share is only 7%. Our industries are now exporting drugs to 72
doi:10.3329/bioethics.v2i1.9813 fatcat:jzcvoab37bhszkicbqbj7rk7aa